GlaxoSmithKline Pharmaceuticals Limited — Others, 14-05-2025: Copy of Newspaper Publication

GlaxoSmithKline Pharmaceuticals Limited has announced a board meeting to consider the financial results for the quarter and half-year, reporting consolidated revenues of ₹966.09 Cr and net profit after tax of ₹262.87 Cr for the quarter, with earnings per share at ₹15.52 after exceptional items. The board has proposed a final dividend of ₹42 per share. Separately, Adonis Medical Systems Pvt Ltd is holding a creditors' meeting to approve a corporate restructuring plan involving Cura Healthcare and 3I Medical Technologies, aimed at streamlining their business operations.